ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.619,40
-1,27%
S&P 500
6.025,99
-0,95%
US Dollar vs BRL
5,8069
0,00%
Bitcoin
96.239,45
-0,32%
Brent Oil
74,565
0,00%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Serina Therapeutics Inc (SER)

  7. Serina Therapeutics Inc (SER) Notícias

SER

Serina Therapeutics (SER)

Serina Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:SER
DataHoraFonteTítuloCódigoCompanhia
03/02/202518:30GlobeNewswire Inc.Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
03/02/202518:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
03/02/202518:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
15/01/202518:05GlobeNewswire Inc.Serina Therapeutics Announces Sale of UniverXome SubsidiaryAMEX:SERSerina Therapeutics Inc
14/01/202519:25GlobeNewswire Inc.Serina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
16/12/202408:00GlobeNewswire Inc.Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024AMEX:SERSerina Therapeutics Inc
11/12/202408:05GlobeNewswire Inc.Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitAMEX:SERSerina Therapeutics Inc
09/12/202418:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:SERSerina Therapeutics Inc
02/12/202419:22GlobeNewswire Inc.Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
22/11/202418:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SERSerina Therapeutics Inc
12/11/202419:00GlobeNewswire Inc.Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
12/11/202418:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SERSerina Therapeutics Inc
11/11/202419:40GlobeNewswire Inc.Serina Therapeutics Makes Grants to New Employees Under Inducement PlanAMEX:SERSerina Therapeutics Inc
06/11/202418:45Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:SERSerina Therapeutics Inc
06/11/202418:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:SERSerina Therapeutics Inc
06/11/202408:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SERSerina Therapeutics Inc
01/11/202410:15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsAMEX:SERSerina Therapeutics Inc
02/10/202409:30GlobeNewswire Inc.Serina Therapeutics to Present at the 14th Annual Injectables SummitAMEX:SERSerina Therapeutics Inc
04/09/202419:42GlobeNewswire Inc.Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:SERSerina Therapeutics Inc
23/08/202418:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:SERSerina Therapeutics Inc
09/08/202417:15GlobeNewswire Inc.Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
29/07/202409:30GlobeNewswire Inc.Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics SummitAMEX:SERSerina Therapeutics Inc
18/07/202418:00GlobeNewswire Inc.Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and FormulationAMEX:SERSerina Therapeutics Inc
17/07/202418:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
10/07/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:SERSerina Therapeutics Inc
14/05/202417:05GlobeNewswire Inc.Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
17/04/202417:05GlobeNewswire Inc.Serina Therapeutics Appoints Dr. Simba Gill as Executive ChairmanAMEX:SERSerina Therapeutics Inc
26/03/202418:04GlobeNewswire Inc.Serina Therapeutics Announces Completion of Merger with AgeX TherapeuticsAMEX:SERSerina Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:AMEX:SER

Seu Histórico Recente

BIT
I06588
Banca Imi
BIT
P1K317
BNP Paribas Issuance
BIT
BS30
Exchange Traded Fund Ivz...
BIT
EUCO
SSgA SPDR ETFs EUROPE I ...
BOV
A1LB34
Albemarle
TG
A2R8XP
NE Property BV
AQSE
SLP.GB
Sylvania Platinum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios